Carole Beaumont - Publications

University Paris 7 

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Millot S, Delaby C, Moulouel B, Lefebvre T, Pilard N, Ducrot N, Ged C, Lettéron P, de Franceschi L, Deybach JC, Beaumont C, Gouya L, De Verneuil H, Lyoumi S, Puy H, et al. Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model. Haematologica. 102: 260-270. PMID 28143953 DOI: 10.3324/Haematol.2016.151621  0.56
2016 Karim Z, Puy H, Beaumont C, Gouya L, Kannengiesser C. Reply. Gastroenterology. PMID 27623323 DOI: 10.1053/j.gastro.2016.09.002  0.56
2016 Daher R, Kannengiesser C, Houamel D, Lefebvre T, Bardou-Jacquet E, Ducrot N, de Kerguenec C, Jouanolle AM, Robreau AM, Oudin C, Le Gac G, Moulouel B, Loustaud-Ratti V, Bedossa P, Valla D, ... ... Beaumont C, et al. Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans. Gastroenterology. 150: 672-683.e4. PMID 26582087 DOI: 10.1053/J.Gastro.2015.10.049  0.56
2016 Houamel D, Ducrot N, Lefebvre T, Daher R, Moulouel B, Sari MA, Letteron P, Lyoumi S, Millot S, Tourret J, Bouvet O, Vaulont S, Vandewalle A, Denamur E, Puy H, ... Beaumont C, et al. Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli. Journal of the American Society of Nephrology : Jasn. 27: 835-46. PMID 26293821 DOI: 10.1681/Asn.2014101035  0.56
2015 Lefebvre T, Dessendier N, Houamel D, Ialy-Radio N, Kannengiesser C, Manceau H, Beaumont C, Nicolas G, Gouya L, Puy H, Karim Z. LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. PMID 25781546 DOI: 10.1515/Cclm-2014-1093  0.56
2014 Oustric V, Manceau H, Ducamp S, Soaid R, Karim Z, Schmitt C, Mirmiran A, Peoc'h K, Grandchamp B, Beaumont C, Lyoumi S, Moreau-Gaudry F, Guyonnet-Dupérat V, de Verneuil H, Marie J, et al. Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria. American Journal of Human Genetics. 94: 611-7. PMID 24680888 DOI: 10.1016/J.Ajhg.2014.02.010  0.32
2013 Delaby C, Oustric V, Schmitt C, Muzeau F, Robreau AM, Letteron P, Couchi E, Yu A, Lyoumi S, Deybach JC, Puy H, Karim Z, Beaumont C, Grandchamp B, Demant P, et al. Epistasis in iron metabolism: complex interactions between Cp, Mon1a, and Slc40a1 loci and tissue iron in mice. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 24: 427-38. PMID 24121729 DOI: 10.1007/S00335-013-9479-6  0.56
2013 De Falco L, Sanchez M, Silvestri L, Kannengiesser C, Muckenthaler MU, Iolascon A, Gouya L, Camaschella C, Beaumont C. Iron refractory iron deficiency anemia. Haematologica. 98: 845-53. PMID 23729726 DOI: 10.3324/Haematol.2012.075515  0.56
2013 Moulouel B, Houamel D, Delaby C, Tchernitchko D, Vaulont S, Letteron P, Thibaudeau O, Puy H, Gouya L, Beaumont C, Karim Z. Hepcidin regulates intrarenal iron handling at the distal nephron. Kidney International. 84: 756-66. PMID 23615502 DOI: 10.1038/Ki.2013.142  0.56
2013 Beaumont C, Karim Z. Iron metabolism: State of the art Revue De Medecine Interne. 34: 17-25. PMID 22595534 DOI: 10.1016/j.revmed.2012.04.006  0.32
2012 Delaby C, Beaumont C. Serum hepcidin assay in 2011: Where do we stand? Annales De Biologie Clinique. 70: 377-386. PMID 22796609 DOI: 10.1684/Abc.2012.0725  0.32
2012 Guillem F, Kannengiesser C, Oudin C, Lenoir A, Matak P, Donadieu J, Isidor B, Méchinaud F, Aguilar-Martinez P, Beaumont C, Vaulont S, Grandchamp B, Nicolas G. Inactive matriptase-2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity. Human Mutation. 33: 1388-96. PMID 22581667 DOI: 10.1002/Humu.22116  0.56
2012 Heming N, Lettéron P, Driss F, Millot S, El Benna J, Tourret J, Denamur E, Montravers P, Beaumont C, Lasocki S. Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*. Critical Care Medicine. 40: 2141-8. PMID 22564959 DOI: 10.1097/Ccm.0B013E31824E6713  0.4
2011 Jeong SY, Crooks DR, Wilson-Ollivierre H, Ghosh MC, Sougrat R, Lee J, Cooperman S, Mitchell JB, Beaumont C, Rouault TA. Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice. Plos One. 6: e25404. PMID 22003390 DOI: 10.1371/Journal.Pone.0025404  0.32
2011 Beaumont C. Can erythroblasts donate iron? Blood. 118: 2649-2651. PMID 21903903 DOI: 10.1182/Blood-2011-07-364372  0.32
2011 Piednoir P, Allou N, Driss F, Longrois D, Philip I, Beaumont C, Montravers P, Lasocki S. Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study. European Journal of Anaesthesiology. 28: 796-801. PMID 21885979 DOI: 10.1097/Eja.0B013E32834Ad97B  0.4
2011 Lyoumi S, Abitbol M, Rainteau D, Karim Z, Bernex F, Oustric V, Millot S, Lettéron P, Heming N, Guillmot L, Montagutelli X, Berdeaux G, Gouya L, Poupon R, Deybach JC, ... Beaumont C, et al. Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model. Gastroenterology. 141: 1509-19, 1519.e1-3. PMID 21762662 DOI: 10.1053/J.Gastro.2011.06.078  0.56
2011 To-Figueras J, Ducamp S, Clayton J, Badenas C, Delaby C, Ged C, Lyoumi S, Gouya L, de Verneuil H, Beaumont C, Ferreira GC, Deybach JC, Herrero C, Puy H. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria. Blood. 118: 1443-51. PMID 21653323 DOI: 10.1182/Blood-2011-03-342873  0.56
2011 Ducamp S, Kannengiesser C, Touati M, Garçon L, Guerci-Bresler A, Guichard JF, Vermylen C, Dochir J, Poirel HA, Fouyssac F, Mansuy L, Leroux G, Tertian G, Girot R, Heimpel H, ... ... Beaumont C, et al. Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations. Human Mutation. 32: 590-7. PMID 21309041 DOI: 10.1002/Humu.21455  0.56
2011 Lasocki S, Longrois D, Montravers P, Beaumont C. Hepcidin and anemia of the critically ill patient: bench to bedside. Anesthesiology. 114: 688-94. PMID 21258235 DOI: 10.1097/01.Sa.0000406388.76161.9B  0.4
2011 Brasse-Lagnel C, Karim Z, Letteron P, Bekri S, Bado A, Beaumont C. Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. Gastroenterology. 140: 1261-1271.e1. PMID 21199652 DOI: 10.1053/J.Gastro.2010.12.037  0.4
2010 Millot S, Andrieu V, Letteron P, Lyoumi S, Hurtado-Nedelec M, Karim Z, Thibaudeau O, Bennada S, Charrier JL, Lasocki S, Beaumont C. Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation. Blood. 116: 6072-81. PMID 20844235 DOI: 10.1182/Blood-2010-04-281840  0.4
2010 Beaumont C. Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages Haematologica. 95: 1233-1236. PMID 20675742 DOI: 10.3324/Haematol.2010.025585  0.32
2010 Callens C, Coulon S, Naudin J, Radford-Weiss I, Boissel N, Raffoux E, Wang PH, Agarwal S, Tamouza H, Paubelle E, Asnafi V, Ribeil JA, Dessen P, Canioni D, Chandesris O, ... ... Beaumont C, et al. Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. The Journal of Experimental Medicine. 207: 731-50. PMID 20368581 DOI: 10.1084/Jem.20091488  0.32
2010 Nahdi A, Hammami I, Brasse-Lagnel C, Pilard N, Hamdaoui MH, Beaumont C, El May M. Influence of garlic or its main active component diallyl disulfide on iron bioavailability and toxicity. Nutrition Research (New York, N.Y.). 30: 85-95. PMID 20226993 DOI: 10.1016/J.Nutres.2010.01.004  0.4
2010 Lasocki S, Baron G, Driss F, Westerman M, Puy H, Boutron I, Beaumont C, Montravers P. Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Medicine. 36: 1044-8. PMID 20213069 DOI: 10.1007/S00134-010-1794-8  0.4
2009 Beaumont C, Delaby C. Recycling Iron in Normal and Pathological States Seminars in Hematology. 46: 328-338. PMID 19786201 DOI: 10.1053/J.Seminhematol.2009.06.004  0.32
2009 Blanco E, Kannengiesser C, Grandchamp B, Tasso M, Beaumont C. Not all DMT1 mutations lead to iron overload Blood Cells, Molecules, and Diseases. 43: 199-201. PMID 19553145 DOI: 10.1016/J.Bcmd.2009.05.003  0.32
2009 Lolascon A, De Falco L, Beaumont C. Molecular basis of inherited microcytic anemia due to defects in iron acquisitionor heme synthesis Haematologica. 94: 395-408. PMID 19181781 DOI: 10.3324/Haematol.13619  0.32
2009 Kannengiesser C, Jouanolle AM, Hetet G, Mosser A, Muzeau F, Henry D, Bardou-Jacquet E, Mornet M, Brissot P, Deugnier Y, Grandchamp B, Beaumont C. A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload Haematologica. 94: 335-339. PMID 19176363 DOI: 10.3324/Haematol.2008.000125  0.32
2008 Lasocki S, Garnier M, Ley L, Benbarra A, Beaumont C, Montravers P. [How is iron prescribed in French ICUs: a practice survey]. Annales Francaises D'Anesthesie Et De Reanimation. 27: 909-14. PMID 18952400 DOI: 10.1016/J.Annfar.2008.08.010  0.44
2008 Whatley SD, Ducamp S, Gouya L, Grandchamp B, Beaumont C, Badminton MN, Elder GH, Holme SA, Anstey AV, Parker M, Corrigall AV, Meissner PN, Hift RJ, Marsden JT, Ma Y, et al. C-Terminal Deletions in the ALAS2 Gene Lead to Gain of Function and Cause X-linked Dominant Protoporphyria without Anemia or Iron Overload American Journal of Human Genetics. 83: 408-414. PMID 18760763 DOI: 10.1016/J.Ajhg.2008.08.003  0.32
2008 Lasocki S, Millot S, Andrieu V, Lettéron P, Pilard N, Muzeau F, Thibaudeau O, Montravers P, Beaumont C. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia. Critical Care Medicine. 36: 2388-94. PMID 18664788 DOI: 10.1097/Ccm.0B013E31818103B9  0.4
2008 Beaumont C, Grandchamp B. The type II membrane-bound serine protease TMPRSS6: An unexpected player in the field of nepcidin gene regulation Hematologie. 14: 335-338. DOI: 10.1684/hma.2008.0279  0.32
2007 Delaby C, Deybach JC, Beaumont C. Hepcidin and iron metabolism Revue De Medecine Interne. 28: 510-512. PMID 17445953 DOI: 10.1016/j.revmed.2007.03.009  0.32
2007 Gouya L, Muzeau F, Robreau AM, Letteron P, Couchi E, Lyoumi S, Deybach JC, Puy H, Fleming R, Demant P, Beaumont C, Grandchamp B. Genetic study of variation in normal mouse iron homeostasis reveals ceruloplasmin as an HFE-hemochromatosis modifier gene. Gastroenterology. 132: 679-86. PMID 17258727 DOI: 10.1053/J.Gastro.2006.11.024  0.56
2007 Lyoumi S, Abitbol M, Andrieu V, Henin D, Robert E, Schmitt C, Gouya L, de Verneuil H, Deybach JC, Montagutelli X, Beaumont C, Puy H. Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice. Blood. 109: 811-8. PMID 17003376 DOI: 10.1182/Blood-2006-04-014142  0.56
2007 Beaumont C. Heme/Fe-S intimacies make RBCs blush Blood. 110: 1085-1086. DOI: 10.1182/Blood-2007-05-091405  0.32
2006 Starzynski RR, Gonçalves AS, Muzeau F, Tyrolczyk Z, Smuda E, Drapier JC, Beaumont C, Lipinski P. STAT5 proteins are involved in down-regulation of iron regulatory protein 1 gene expression by nitric oxide. The Biochemical Journal. 400: 367-75. PMID 16886906 DOI: 10.1042/Bj20060623  0.4
2006 Gonçalves AS, Muzeau F, Blaybel R, Hetet G, Driss F, Delaby C, Canonne-Hergaux F, Beaumont C. Wild-type and mutant ferroportins do not form oligomers in transfected cells. The Biochemical Journal. 396: 265-75. PMID 16457665 DOI: 10.1042/BJ20051682  0.4
2006 Gouya L, Martin-Schmitt C, Robreau AM, Austerlitz F, Da Silva V, Brun P, Simonin S, Lyoumi S, Grandchamp B, Beaumont C, Puy H, Deybach JC. Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria. American Journal of Human Genetics. 78: 2-14. PMID 16385445 DOI: 10.1086/498620  0.56
2005 Beaumont C. Ferroportin in erythroid cells: A protective mechanism? Haematologica. 90: 1585. PMID 16330420  0.32
2005 Schmitt C, Gouya L, Malonova E, Lamoril J, Camadro JM, Flamme M, Rose C, Lyoumi S, Da Silva V, Boileau C, Grandchamp B, Beaumont C, Deybach JC, Puy H. Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria. Human Molecular Genetics. 14: 3089-98. PMID 16159891 DOI: 10.1093/Hmg/Ddi342  0.56
2005 Delaby C, Pilard N, Hetet G, Driss F, Grandchamp B, Beaumont C, Canonne-Hergaux F. A physiological model to study iron recycling in macrophages. Experimental Cell Research. 310: 43-53. PMID 16095591 DOI: 10.1016/J.Yexcr.2005.07.002  0.4
2005 Delaby C, Pilard N, Gonçalves AS, Beaumont C, Canonne-Hergaux F. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood. 106: 3979-84. PMID 16081696 DOI: 10.1182/Blood-2005-06-2398  0.4
2005 Beaumont C. Antiapoptotic role of ferritin heavy chain Medecine/Sciences. 21: 591-592. PMID 15985200 DOI: 10.1051/Medsci/2005216-7591  0.32
2005 Beaumont C, Canonne-Hergaux F. Erythrophagocytosis and recycling of heme iron in normal and pathological conditions; regulation by hepcidin Transfusion Clinique Et Biologique. 12: 123-130. PMID 15927501 DOI: 10.1016/j.tracli.2005.04.017  0.32
2004 Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, Jayawardena S, De Smaele E, Cong R, Beaumont C, Torti FM, Torti SV, Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell. 119: 529-42. PMID 15537542 DOI: 10.1016/J.Cell.2004.10.017  0.32
2004 Martin ME, Nicolas G, Hetet G, Vaulont S, Grandchamp B, Beaumont C. Transferrin receptor 1 mRNA is downregulated in placenta of hepcidin transgenic embryos. Febs Letters. 574: 187-91. PMID 15358563 DOI: 10.1016/J.Febslet.2004.08.010  0.32
2004 Beaumont C. Molecular mechanisms of iron homeostasis Medecine/Sciences. 20: 68-72. PMID 14770366 DOI: 10.1051/Medsci/200420168  0.32
2004 Moura IC, Lepelletier Y, Arnulf B, England P, Baude C, Beaumont C, Bazarbachi A, Benhamou M, Monteiro RC, Hermine O. A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients. Blood. 103: 1838-45. PMID 14592824 DOI: 10.1182/Blood-2003-07-2440  0.32
2003 Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC. Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. Journal of Neurochemistry. 86: 1142-8. PMID 12911622 DOI: 10.1046/J.1471-4159.2003.01923.X  0.32
2002 Faucheux BA, Martin ME, Beaumont C, Hunot S, Hauw JJ, Agid Y, Hirsch EC. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. Journal of Neurochemistry. 83: 320-30. PMID 12423242 DOI: 10.1046/J.1471-4159.2002.01118.X  0.32
2002 Tchernitchko D, Bourgeois M, Martin ME, Beaumont C. Expression of the two mRNA isoforms of the iron transporter Nramp2/DMTI in mice and function of the iron responsive element. The Biochemical Journal. 363: 449-55. PMID 11964145 DOI: 10.1042/Bj3630449  0.32
2001 Ferreira C, Santambrogio P, Martin ME, Andrieu V, Feldmann G, Hénin D, Beaumont C. H ferritin knockout mice: a model of hyperferritinemia in the absence of iron overload. Blood. 98: 525-32. PMID 11468145 DOI: 10.1182/BLOOD.V98.3.525  0.4
2000 Giordani A, Martin ME, Beaumont C, Santus R, Morlière P. Inactivation of iron responsive element-binding capacity and aconitase function of iron regulatory protein-1 of skin cells by ultraviolet A. Photochemistry and Photobiology. 72: 746-52. PMID 11140262 DOI: 10.1562/0031-8655(2000)072<0746:Ioireb>2.0.Co;2  0.32
1998 Corsi B, Perrone F, Bourgeois M, Beaumont C, Panzeri MC, Cozzi A, Sangregorio R, Santambrogio P, Albertini A, Arosio P, Levi S. Transient overexpression of human H- and L-ferritin chains in COS cells. The Biochemical Journal. 330: 315-20. PMID 9461525 DOI: 10.1042/Bj3300315  0.32
1996 Gérard B, Farman N, Raja KB, Eugène E, Grandchamp B, Beaumont C. Expression of H and L ferritin mRNAs in mouse small intestine. Experimental Cell Research. 228: 8-13. PMID 8892964 DOI: 10.1006/Excr.1996.0292  0.32
1996 Beaumont C, Torti SV, Torti FM, Massover WH. Novel properties of L-type polypeptide subimits in mouse ferritin molecules Journal of Biological Chemistry. 271: 7923-7926. PMID 8626471 DOI: 10.1074/Jbc.271.14.7923  0.32
1995 Kwak EL, Larochelle DA, Beaumont C, Torti SV, Torti FM. Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. The Journal of Biological Chemistry. 270: 15285-93. PMID 7797515 DOI: 10.1074/Jbc.270.25.15285  0.32
1987 Grandchamp B, de Verneuil H, Beaumont C, Chretien S, Walter O, Nordmann Y. Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene European Journal of Biochemistry. 162: 105-110. PMID 3816774 DOI: 10.1111/J.1432-1033.1987.Tb10548.X  0.32
1979 Beaumont C, Piau JP, Fischer S, Delaunay J, Schapira G. Stimulation of erythroid cells adenylate cyclase by soluble factors. Biochemical and Biophysical Research Communications. 91: 1250-7. PMID 526301 DOI: 10.1016/0006-291X(79)91201-4  0.32
Show low-probability matches.